613 related articles for article (PubMed ID: 20843473)
21. Comparative analysis of phosphoethanolamine transferases involved in polymyxin resistance across 10 clinically relevant Gram-negative bacteria.
Huang J; Zhu Y; Han ML; Li M; Song J; Velkov T; Li C; Li J
Int J Antimicrob Agents; 2018 Apr; 51(4):586-593. PubMed ID: 29288722
[TBL] [Abstract][Full Text] [Related]
22. [Aminoglycosides and polymyxins].
Molina J; Cordero E; Palomino J; Pachón J
Enferm Infecc Microbiol Clin; 2009 Mar; 27(3):178-88. PubMed ID: 19303668
[TBL] [Abstract][Full Text] [Related]
23. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review.
Zavascki AP; Goldani LZ; Li J; Nation RL
J Antimicrob Chemother; 2007 Dec; 60(6):1206-15. PubMed ID: 17878146
[TBL] [Abstract][Full Text] [Related]
24. Importance of antibiotic resistance and resistance mechanisms. Foreword.
Bonomo RA; Rossolini GM
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):549-50. PubMed ID: 18847392
[No Abstract] [Full Text] [Related]
25. Adaptive resistance to cationic compounds in Pseudomonas aeruginosa.
Skiada A; Markogiannakis A; Plachouras D; Daikos GL
Int J Antimicrob Agents; 2011 Mar; 37(3):187-93. PubMed ID: 21295448
[TBL] [Abstract][Full Text] [Related]
26. Polymyxin antibiotics for gram-negative infections.
Arnold TM; Forrest GN; Messmer KJ
Am J Health Syst Pharm; 2007 Apr; 64(8):819-26. PubMed ID: 17420197
[TBL] [Abstract][Full Text] [Related]
27. Optimizing use of colistin and polymyxin B in the critically ill.
Nation RL; Li J
Semin Respir Crit Care Med; 2007 Dec; 28(6):604-14. PubMed ID: 18095224
[TBL] [Abstract][Full Text] [Related]
28. Polymyxins for the treatment of extensively-drug-resistant Gram-negative bacteria: from pharmacokinetics to bedside.
Zavascki AP
Expert Rev Anti Infect Ther; 2014 May; 12(5):531-3. PubMed ID: 24666285
[TBL] [Abstract][Full Text] [Related]
29. Combination therapy for carbapenem-resistant Gram-negative bacteria.
Zavascki AP; Bulitta JB; Landersdorfer CB
Expert Rev Anti Infect Ther; 2013 Dec; 11(12):1333-53. PubMed ID: 24191943
[TBL] [Abstract][Full Text] [Related]
30. Teaching 'old' polymyxins new tricks: new-generation lipopeptides targeting gram-negative 'superbugs'.
Velkov T; Roberts KD; Nation RL; Wang J; Thompson PE; Li J
ACS Chem Biol; 2014 May; 9(5):1172-7. PubMed ID: 24601489
[TBL] [Abstract][Full Text] [Related]
31. In vitro activities of antimicrobials against six important species of gram-negative bacteria isolated from raw milk samples in Korea.
Nam HM; Lim SK; Kim JM; Joo YS; Jang KC; Jung SC
Foodborne Pathog Dis; 2010 Feb; 7(2):221-4. PubMed ID: 19895257
[TBL] [Abstract][Full Text] [Related]
32. Antibiotic resistance. Nosocomial gram-negative infection.
Gransden WR
J Med Microbiol; 1997 Jun; 46(6):436-9. PubMed ID: 9379467
[No Abstract] [Full Text] [Related]
33. The challenge of multidrug resistance: the treatment of gram-negative rod infections.
Levin AS; Oliveira MS
Shock; 2008 Oct; 30 Suppl 1():30-3. PubMed ID: 18704012
[TBL] [Abstract][Full Text] [Related]
34. Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa.
McPhee JB; Lewenza S; Hancock RE
Mol Microbiol; 2003 Oct; 50(1):205-17. PubMed ID: 14507375
[TBL] [Abstract][Full Text] [Related]
35. Antimicrobial Susceptibility Testing for Polymyxins: Challenges, Issues, and Recommendations.
Ezadi F; Ardebili A; Mirnejad R
J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30541939
[TBL] [Abstract][Full Text] [Related]
36. Multidrug-Resistant Gram-Negative Pathogens: The Urgent Need for 'Old' Polymyxins.
Paterson DL; Bonomo RA
Adv Exp Med Biol; 2019; 1145():9-13. PubMed ID: 31364068
[TBL] [Abstract][Full Text] [Related]
37. Polymyxin Resistance in Acinetobacter baumannii: Genetic Mutations and Transcriptomic Changes in Response to Clinically Relevant Dosage Regimens.
Cheah SE; Johnson MD; Zhu Y; Tsuji BT; Forrest A; Bulitta JB; Boyce JD; Nation RL; Li J
Sci Rep; 2016 May; 6():26233. PubMed ID: 27195897
[TBL] [Abstract][Full Text] [Related]
38. Multidrug resistant gram-negative bacteria in clinical isolates from Karachi.
Saeed A; Khatoon H; Ansari FA
Pak J Pharm Sci; 2009 Jan; 22(1):44-8. PubMed ID: 19168419
[TBL] [Abstract][Full Text] [Related]
39. Clinical translation of polymyxin-based combination therapy: Facts, challenges and future opportunities.
Zhang X; Guo F; Shao H; Zheng X
J Infect; 2017 Feb; 74(2):118-130. PubMed ID: 27998750
[TBL] [Abstract][Full Text] [Related]
40. Comparative analysis of antibiotic resistance characteristics of Gram-negative bacteria isolated from laying hens and eggs in conventional and organic keeping systems in Bavaria, Germany.
Schwaiger K; Schmied EM; Bauer J
Zoonoses Public Health; 2008 Sep; 55(7):331-41. PubMed ID: 18667026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
